MSK/Diagnostic Uncertainty service

  • NHS Frimley Integrated Care Board

F14: Notice for changes or additional information

Notice identifier: 2024/S 000-039188

Procurement identifier (OCID): ocds-h6vhtk-047d54

Published 5 December 2024, 10:31am



Section one: Contracting authority/entity

one.1) Name and addresses

NHS Frimley Integrated Care Board

Windsor

SL4 3DP

Email

scwcsu.cbprocurement@nhs.net

Country

United Kingdom

Region code

UKJ37 - North Hampshire

Justification for not providing organisation identifier

Not on any register

Internet address(es)

Main address

https://www.frimley.icb.nhs.uk


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

MSK/Diagnostic Uncertainty service

Reference number

DAC3

two.1.2) Main CPV code

  • 85100000 - Health services

two.1.3) Type of contract

Services

two.1.4) Short description

NHS Frimley ICB ("the Commissioner") sought to commission Dr K Lothe and Partners LLP to provide an MSK/Diagnostic Uncertainty service.

MSK/Diagnostic Uncertainty service for Surrey Heath is for patients aged over 18.

The service is a multi-disciplinary community advice, assessment and treatment service to support GPs and community physiotherapists in diagnostic assessment and treatment planning for patients with challenging MSK conditions; i.e. patients where diagnostic uncertainly exists and/or the patient has been unresponsive to previous treatments.

The normal referral route into the service is via a patient's GP. Referrals are also received from Community Physiotherapy providers for diagnostic uncertainty. The initial face-to-face clinical assessment uses a biopsychosocial model, and draws on a multi-disciplinary team of experts. It includes access to biomechanical, pharmacological and psychological assessment.

The aim of the clinical assessment is to identify a diagnosis, where possible, support the referrer and patient in the management of ongoing symptoms where there continues to be diagnostic uncertainty, develop and implement an agreed treatment and/or management plan.

The majority of patients after the initial assessment will be:

- Referred back to the GP with a diagnosis and clear management plan or

- Referred to the community physiotherapy services (Choice of provider to be offered at point of referral) or

- Identified as suitable for the Community Pain Service or

- Referred on to services outside community services.

Treatments are limited to:

- Non-ultrasound guided injections / Ultrasound guided injections

- Advice and signposting to supported self-management and positive lifestyle options, including physical activity and weight management, smoking and diet

- Pharmacological management advice including managing medication and flare-ups.

Follow-up appointments are also provided under this pathway.


Section six. Complementary information

six.6) Original notice reference

Notice number: 2024/S 000-021623


Section seven. Changes

seven.1) Information to be changed or added

seven.2) Other additional information

Contract Awarded 1st July 2024 expiring 30th June 2025 (contract length one year + optional one year extension)

The full expected lifetime of the contract value (one year + optional one year extension) is £796,167.36

This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. This contract has now been formally awarded using direct award process C.